Nitric oxide causes a cGMP-independent intracellular calcium rise in porcine endothelial cells - A paradox?

Microvascular Research

Volumn 59, Issue 1, 2000, Pages 38-44

  Berkels, Reinhard ^a   Suerhoff, Stefan ^a   Roesen, Renate ^a   Klaus, Wolfgang ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

CGMP; Endothelium; Intracellular calcium; NO; NO donors

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC GMP; ARGININE DERIVATIVE; CALCIUM; CALCIUM CHANNEL; CYCLIC GMP; GUANYLATE CYCLASE; NITRIC OXIDE; NITRIC OXIDE DONOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; ENDOTHELIUM CELL; ENZYME INHIBITION; EXTRACELLULAR CALCIUM; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 0033957026     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.1999.2191     Document Type: Article

References (31)

1. Archer S. Measurement of nitric oxide in biological models. FASEB J. 7:1993;349.
2. Berkels R., Bertsch A., Breitenbach T., Klaus W., Roesen R. The calcium antagonist nifedipine stimulates endothelial NO release in therapeutical concentrations. Pharm. Pharmacol. Lett. 6:1996;75.
3. i and NO in endothelial cells. Therapeut. 4:1999;175.
4. Blatter L. A., Wier W. G. Nitric oxide decreases [Ca2+]i in vascular smooth muscle by inhibition of the calcium current. Cell Calcium. 15:1994;122.
5. Bolotina V. M., Najibi S., Palacino J. J., Pagano P. J., Cohen R. A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 368:1994;850.
6. Buchan K. W., Martin W. Modulation of agonist-induced calcium mobilisation in bovine aortic endothelial cells by phorbol myristate acetate and cyclic AMP but not cyclic GMP. Br. J. Pharmacol. 104:1991;361.
7. Buga G. M., Griscavage J. M., Rogers N. E., Ignarro L. J. Negative feedback regulation of endothelial cell function by nitric oxide. Circ. Res. 73:1993;808.
8. Carrier G. O., Fuchs L. C., Winecoff A. P., Giulumian A. D., White R. E. Nitrovasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels, Am. J. Physiol. 273:1997;H76.
9. Forstermann U., Closs E. I., Pollock J. S., Nakane M., Schwarz P., Gath I., Kleinert H. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension. 23:1994;1121.
10. Fukuta H., Miwa K., Hozumi T., Yamamoto Y., Suzuki H. Inhibitory actions of endothelial products on mechanical and calcium responses in aortic smooth muscle cells. J. Smooth Muscle Res. 33:1997;49.
11. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373.
12. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440.
13. Haller H. Endothelial function. General considerations. Drugs. 53:1997;1.
14. He P., Zeng M., Curry F. E. Effect of nitric oxide synthase inhibitors on basal microvessel permeability and endothelial cell [Ca2+]i. Am. J. Physiol. 273:1997;H747.
15. Ignarro L. J., Buga G. M., Wood K. S., Byrns R. E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA. 84:1987;9265.
16. ++ release elicited by inositol trisphosphate but not caffeine in rat vascular smooth muscle. J. Pharmacol. Exp. Ther. 285:1998;16.
17. Komalavilas P., Lincoln T. M. Phosphorylation of the inositol 1,4,5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta. J. Biol. Chem. 271:1996;21933.
18. Lincoln T. M., Cornwell T. L. Intracellular cyclic GMP receptor proteins. FASEB J. 7:1993;328.
19. Ma X. L., Lopez B. L., Christopher T. A., Birenbaum D. S., Vinten-Johansen J. Exogenous NO inhibits basal NO release from vascular endothelium in vitro and in vivo. Am. J. Physiol. 271:1996;H2045.
20. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109.
21. Palmer R. M., Ashton D. S., Moncada S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature. 333:1988;664.
22. Publicover N. G., Hammond E. M., Sanders K. M. Amplification of nitric oxide signaling by interstitial cells isolated from canine colon. Proc. Natl. Acad. Sci. USA. 90:1993;2087.
23. Radomski M. W., Palmer R. M., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 2:1987;1057.
24. Rand M. J. nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission. Clin. Exp. Pharmacol. Physiol. 19:1992;147.
25. Schilling W. P., Cabello O. A., Rajan L. Depletion of the inositol 1,4,5-trisphosphate-sensitive intracellular Ca2+ store in vascular endothelial cells activates the agonist- sensitive Ca(2+)-influx pathway. Biochem. J. 284:1992;521.
26. Schwarz G., Droogmans G., Nilius B. Multiple effects of SK&F 96365 on ionic currents and intracellular calcium in human endothelial cells. Cell Calcium. 15:1994;45.
27. Shami P. J., Sauls D. L., Weinberg J. B. Schedule and concentration-dependent induction of apoptosis in leukemia cells by nitric oxide. Leukemia. 12:1998;1461.
28. Vaandrager A. B., de Jonge H. R. Signalling by cGMP-dependent protein kinases. Mol. Cell. Biochem. 157:1996;23.
29. 2+ changes in endothelial cells independent of cGMP. J. Cell. Physiol. 172:1997;296.
30. Willmott N., Sethi J. K., Walseth T. F., Lee H. C., White A. M., Galione A. Nitric oxide-induced mobilization of intracellular calcium via the cyclic ADP-ribose signaling pathway. J. Biol. Chem. 271:1996;3699.
31. Zhang J. C., Wogan G. N. Growth and viability of macrophages continuously stimulated to produce nitric oxide. Proc. Natl. Acad. Sci. USA. 94:1997;11875.